Is Sensorion SA halal to invest in?

According to Musaffa's Shariah screening methodology, Sensorion SA (ALSEN.PA) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Sensorion SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Sensorion SA using these criteria to determine its compliance status.

Can Muslims buy shares of Sensorion SA?

Muslim investors may consider investing in Sensorion SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Sensorion SA classified as NOT HALAL?

Musaffa determines the Shariah status of Sensorion SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Sensorion SA updated?

The Shariah compliance status of Sensorion SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Sensorion SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Sensorion SA?

You can check the latest Shariah compliance status of Sensorion SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Sensorion SA ALSEN.PA

€0.40 €0.02 (4.76%) 1D

Last Updated: May 15, 12:00 AM·XPAR

ALSEN.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 05, 2026

Report Source: 2025 2nd Quarter Report

Sensorion SA. Stock Analysis ALSEN.PA

France Health Care Micro Cap Report: Q2, 2025

Sensorion SA is a biopharmaceutical company, which engages in the development of therapies to treat and prevent diseases of the inner ear such as deafness, vertigo, and tinnitus. The company is headquartered in Montpellier, Occitanie and currently employs 63 full-time employees. The company went IPO on 2015-04-21. The firm is principally active in the development of targeted therapeutic solutions to treat inner ear diseases. The firm develops also drug treatments, from molecular biology all the way to animal pharmacology, toxicology, and clinical research and therapeutic solutions to treat vestibular deficits. Sensorion SA is a spin-off of the research team Pathophysiology and Therapy of Vestibular Deficits in Montpellier Neuroscience Institute.

Key Statistics of Sensorion SA (ALSEN.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.40€0.42

Today's Open

€0.42

Volume

17.38K

P/E Ratio (TTM)

52 Week Range

€0.27€0.81

Market Cap

199.46M

Avg. Volume

290.95K

Dividend Yield

Financial Metrics & Statements of Sensorion SA (ALSEN.PA)

FAQ's for Sensorion SA (ALSEN.PA)

According to Musaffa’s Shariah screening methodology, Sensorion SA (ALSEN.PA) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.